PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, will present interim data from the COSMOS study supporting the use of Guardant Reveal to ...
By Dennis Thompson HealthDay ReporterWEDNESDAY, Jan. 7, 2026 (HealthDay News) — Ozempic and Wegovy might help people avoid ...
Occasional constipation is common, but doctors warn that constipation lasting for months may signal colon cancer, especially ...
Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...
Patients with symptoms of gastrointestinal (GI) problems and survivors of colon cancer were more likely to use oncology specialty care. Oncologic specialty care was more often used in colon cancer ...
One large study found that more advanced cases of colorectal cancer had a higher likelihood of returning. For example, if participants had stage 3 colon cancer, almost 25 percent experienced a ...
Please provide your email address to receive an email when new articles are posted on . CHICAGO — Circulating tumor DNA analysis safely reduced adjuvant chemotherapy use without compromising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback